May 15, 2007 - BARRX Medical, Inc. announced at Digestive Disease Week in Washington, D.C., results of a clinical trial in which 96 percent of patients with advanced stages of Barrett's esophagus, dysplasia and early cancer, who were treated with the HALO Ablation System, an endoscopic device which removes diseased tissue without the need for surgery, were cured of the disease, with average follow-up exceeding one year. Additionally, all genetic abnormalities associated with developing cancer of the esophagus were reportedly eliminated after treatment.
In this study, patients with the most advanced stages of Barrett's esophagus (dysplasia and early cancer) received ablation using the HALO360 Ablation System, a balloon-based ablation device designed to remove the diseased cells using controlled heat. Procedures were performed non-surgically, using endoscopy and sedation, which allowed the patient to return to normal activity after the procedure. Patients then underwent focal ablation with the HALO90 Ablation System, a smaller device that mounts on the endoscope and is designed to treat small residual areas of Barrett's esophagus. Patients had endoscopy with biopsy to confirm elimination of the disease, as well as genetic testing of the new healed tissue to determine if genetic abnormalities had been eliminated.
“We have been successful in using the HALO Ablation System for the treatment of patients with dysplasia and early cancer of their esophagus,” said Jacques Bergman, M.D., associate professor, Department of Gastroenterology, Academic Medical Center, Amsterdam, the Netherlands, the senior investigator for this study. “Until now, the patient with advanced stages of Barrett's esophagus would receive an esophagectomy or various endoscopic therapies, which are often associated safety risks. The results of this study suggest that not only can we safely and completely remove the diseased esophageal tissue, but we can also eliminate all the genetic abnormalities associated with developing esophageal cancer in the future.”


Related Content

News | Endoscopes

December 23, 2019 — The U.S. Food and Drug Administration cleared for marketing in the U.S. the first fully disposable ...

Time December 23, 2019
arrow
News | Endoscopes

December 23, 2019 — Boston Scientific Corporation announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Time December 23, 2019
arrow
News | Endoscopes

October 22, 2019 — OmniVision Technologies Inc. announced that its OV6948 camera module is the winner of the Guinness ...

Time October 22, 2019
arrow
News | Endoscopes

Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with advanced visualization capabilities designed for both diagnostic and therapeutic hysteroscopic procedures. Obstetricians and gynecologists (ObGyns) can use the new Omni hysteroscope in out- and inpatient settings.

Time March 14, 2019
arrow
Videos | Advanced Visualization

This is an example of a new endoscopic virtual peritoneal inflation tool on the patient's computed tomography (CT) ...

Time March 05, 2019
arrow
Videos | Advanced Visualization

This is an example of a new endoscopic 3-D imaging simulator created from a patient's computed tomography (CT) scan ...

Time March 05, 2019
arrow
Technology | Advanced Visualization

Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla. The latest Synapse 3D Advanced Visualization software introduces five new applications, in addition to its current 50 clinical applications, that will be available for demonstration.

Time February 08, 2019
arrow
Technology | Lung Imaging

Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its LungVision platform. The platform will be presented at the CHEST conference, Oct. 7-10 in San Antonio, Texas.

Time October 05, 2018
arrow
News | Endoscopes

During the 2018 Digestive Disease Week (DDW) conference June 2-5 in Washington, D.C., the American Society for Gastrointestinal Endoscopy (ASGE), in collaboration with Touch Surgery, demonstrated three mobile-accessed and video-based simulations at ASGE’s Learning Center. Working closely with ASGE, Touch Surgery was able to convert endoscopic procedural videos into interactive mini-simulations.

Time June 11, 2018
arrow
News | Ultrasound Imaging

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures ...

Time June 04, 2018
arrow
Subscribe Now